BACKROUND: The feasibility of a novel skull base approach, the navigated minimal ly invasive presigmoidal suprabulbar infralabyrinthine approach (NaMIPSI-A) without rerouting of the fallopian canal for selected jugular foramen tumors (JFTs), has been demonstrated in a neuroanatomical laboratory study.OBJECTIVE: Here, we present our clinical experience with this approach for selected JFTs, with a particular focus on its e cacy and safety.METHODS: All patients with JFTs who were treated via the NaMIPSI-A were included in this study. The JFTs were classi ed according to a modi ed Fisch classi cation. The neurological and neuroradiological outcome, the extent of tumor resection, and the approach-related morbidity were examined.RESULTS: Five patients (two women, three men; mean age 57y, range 48-65) were available. According to the modi ed Fisch classi cation, two JFTs were graded as C1, one as De1 and two as De2. Gross total resection (GTR) was achieved in three patients and near-total resection (NTR) in two. Postsurgically, no new neurological de cits and no approach-related morbidity and mortality occurred. One case with a postoperative cerebrospinal uid leak was managed successfully with lumbar drainage. During the follow-up period (mean 67,6 months, range 12-119 months) tumor recurrence was noted in the NTR group but not in the GTR group.CONCLUSIONS: The NaMIPSI-A to the jugular foramen without rerouting of the fallopian canal is highly valuable for selected tumors of the jugular foramen. It is less invasive than other skull approaches, and it allows safe and complete tumor removal in appropriate patients.